US OptionsDetailed Quotes

MDWD250117C9000

Watchlist

0.00
0.000.00%

15min DelayClose Jan 3 09:30 ET

0.00High0.00Low

MediWound Stock Discussion

Jaguar8

Dec 17, 2024 07:09

NEWS

$MediWound (MDWD.US)$
MediWound to Host Virtual Key Opinion Leader Event to Discuss EscharEx® Phase III VALUE Study in Venous Leg Ulcers and Its Commercial Opportunity on January 8, 2025
Tuesday, 17th December at 8:00 am
YAVNE, Israel, Dec. 17, 2024 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced it will host a virtual Key Opinion Leader (KOL) event on Wednesday, January 8, 2025, at 10:00 AM ET. T...

Trytosaveabit

Aug 15, 2024 15:19

News

$MediWound (MDWD.US)$ Reuters
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns

Trytosaveabit

Jul 15, 2024 06:04

Update

$MediWound (MDWD.US)$ Mediwound Ltd - to Sell 1,453,488 Ordinary Shares at 17.20 PS

careful Llama_7306

Jul 5, 2024 08:47

$MediWound (MDWD.US)$ any thoughts??

Trytosaveabit

Jul 5, 2024 07:27

Hmm?

$MediWound (MDWD.US)$ Watching / Looking for confirmation of rumor that $Solventum (SOLV.US)$ is offering a $34 PS takeover bid?

Trytosaveabit

Jan 9, 2024 06:05

Update

$MediWound (MDWD.US)$ MediWound Says FDA Accepted For Review The Supplement To The NexoBrid BLA To Include Pediatric Patients With Severe Thermal Burns

Trytosaveabit

Dec 28, 2023 06:06

It’s a additional 6.7 Million in non dilutive funding

$MediWound (MDWD.US)$

Trytosaveabit

Dec 28, 2023 06:02

Update

$MediWound (MDWD.US)$ MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army 1 MINUTE AGO, 7:00 AM EST VIA GLOBENEWSWIRE

Trytosaveabit

Dec 21, 2023 07:16

Go ahead look at the daily chart since I brought this to your attention! Hehehe

$MediWound (MDWD.US)$ Dare ya!

Moomoo AI

Dec 19, 2023 01:55

MediWound's high P/S ratio and weaker growth forecast compared to the wider industry could worry investors. Without significant business improvement, the stock price may face a drop risk.

Optimistic Investors Push MediWound Ltd. (NASDAQ:MDWD) Shares Up 26% But Growth Is Lacking

No comment yet